Report Overview
Report Summary
Eternity Insights has published a new study on Global Antidote Market focusing on key segments as by Type (Chemical Antidotes,Physical Antidotes,Pharmacological Antidotes, Other), by Application (Pesticide Poisoning,Heavy Metal Poisoning,Animal Bites Poisoning,Cyanide Poisoning,Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Antidote Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Antidote Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Antidote Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Antidote Market Segmentation:
Antidote Market, By Type
- Chemical Antidotes
- Physical Antidotes
- Pharmacological Antidotes
- Other
Antidote Market, By Application
- Pesticide Poisoning
- Heavy Metal Poisoning
- Animal Bites Poisoning
- Cyanide Poisoning
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Antidote market in terms of demand generation. The Antidote market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Antidote market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Antidote Market Taxonomy:
To learn more about this report
Global Antidote Market Competitive Landscape
The global Antidote market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Roche
- Pfizer
- Bayer
- Johnson & Johnson
- Novartis
- Eli Lilly
- Teva
- Boehringer Ingelheim
- Mylan
- Fresenius Kabi
- Baxter
- Furen Pharmaceutical
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Chemical Antidotes,Physical Antidotes,Pharmacological Antidotes, Other |
| By Application Outlook |
Pesticide Poisoning,Heavy Metal Poisoning,Animal Bites Poisoning,Cyanide Poisoning,Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Roche,Pfizer,Bayer,Johnson & Johnson,Novartis,Eli Lilly,Teva,Boehringer Ingelheim,Mylan,Fresenius Kabi,Baxter,Furen Pharmaceutical |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table Of Contents
Table of Contents
Global Antidote Market Report 2020, Forecast to 2027
1 Scope of the Study
1.1 Antidote Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 Antidote Industry Overview
2.1 Global Antidote Market Size (Million USD) Comparison by Regions (2020-2027)
2.1.1 Antidote Global Import Market Analysis
2.1.2 Antidote Global Export Market Analysis
2.1.3 Antidote Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Chemical Antidotes
2.2.2 Physical Antidotes
2.2.3 Pharmacological Antidotes
2.3.2 Heavy Metal Poisoning
2.3.3 Animal Bites Poisoning
2.3.4 Cyanide Poisoning
2.3.5 Others
2.4.2 Global Antidote Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Antidote Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Antidote Manufacturer Market Share
2.4.5 Top 10 Antidote Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Antidote Market
2.4.7 Key Manufacturers Antidote Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Antidote Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
3 Upstream and Downstream Market Analysis
3.1 Upstream Analysis
3.1.1 Macro Analysis of Upstream Markets
3.1.2 Key Players in Upstream Markets
3.1.3 Upstream Market Trend Analysis
3.1.4 Antidote Manufacturing Cost Analysis
3.2 Downstream Market Analysis
3.2.1 Macro Analysis of Down Markets
3.2.2 Key Players in Down Markets
3.2.3 Downstream Market Trend Analysis
3.2.4 Sales Channel, Distributors, Traders and Dealers
4 Global Antidote Market Size Categorized by Regions
4.1 Global Antidote Revenue, Sales and Market Share by Regions
4.1.1 Global Antidote Sales and Market Share by Regions (2015-2020)
4.1.2 Global Antidote Revenue and Market Share by Regions (2015-2020)
4.2 Europe Antidote Sales and Growth Rate (2015-2020)
4.3 APAC Antidote Sales and Growth Rate (2015-2020)
4.4 North America Antidote Sales and Growth Rate (2015-2020)
4.5 South America Antidote Sales and Growth Rate (2015-2020)
4.6 Middle East & Africa Antidote Sales and Growth Rate (2015-2020)
5 Europe Antidote Market Size Categorized by Countries
5.1 Europe Antidote Sales, Revenue and Market Share by Countries
5.1.1 Europe Antidote Sales by Countries (2015-2020)
5.1.2 Europe Antidote Revenue by Countries (2015-2020)
5.1.3 Germany Antidote Sales and Growth Rate (2015-2020)
5.1.4 UK Antidote Sales and Growth Rate (2015-2020)
5.1.5 France Antidote Sales and Growth Rate (2015-2020)
5.1.6 Russia Antidote Sales and Growth Rate (2015-2020)
5.1.7 Italy Antidote Sales and Growth Rate (2015-2020)
5.1.8 Spain Antidote Sales and Growth Rate (2015-2020)
5.2 Europe Antidote Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Antidote Sales, Revenue and Market Share by Type (2015-2020)
5.3.1 Europe Antidote Sales Market Share by Type (2015-2020)
5.3.2 Europe Antidote Revenue and Revenue Share by Type (2015-2020)
5.4 Europe Antidote Sales Market Share by Application (2015-2020)
6 Asia-Pacific Antidote Market Size Categorized by Countries
6.1 Asia-Pacific Antidote Sales, Revenue and Market Share by Countries
6.1.1 Asia-Pacific Antidote Sales by Countries (2015-2020)
6.1.2 Asia-Pacific Antidote Revenue by Countries (2015-2020)
6.1.3 China Antidote Sales and Growth Rate (2015-2020)
6.1.4 Japan Antidote Sales and Growth Rate (2015-2020)
6.1.5 Korea Antidote Sales and Growth Rate (2015-2020)
6.1.6 India Antidote Sales and Growth Rate (2015-2020)
6.1.7 Southeast Asia Antidote Sales and Growth Rate (2015-2020)
6.1.8 Australia Antidote Sales and Growth Rate (2015-2020)
6.2 Asia-Pacific Antidote Sales and Revenue (Value) by Manufacturers (2018-2020)
6.3 Asia-Pacific Antidote Sales, Revenue and Market Share by Type (2015-2020)
6.3.1 Asia-Pacific Antidote Sales Market Share by Type (2015-2020)
6.3.2 Asia-Pacific Antidote Revenue and Revenue Share by Type (2015-2020)
6.4 Asia-Pacific Antidote Sales and Market Share by Application (2015-2020)
7 North America Antidote Market Size Categorized by Countries
7.1 North America Antidote Sales, Revenue and Market Share by Countries
7.1.1 North America Antidote Sales by Countries (2015-2020)
7.1.2 North America Antidote Revenue by Countries (2015-2020)
7.1.3 United States Antidote Sales and Growth Rate (2015-2020)
7.1.4 Canada Antidote Sales and Growth Rate (2015-2020)
7.1.5 Mexico Antidote Sales and Growth Rate (2015-2020)
7.2 North America Antidote Revenue (Value) by Manufacturers (2018-2020)
7.3 North America Antidote Sales, Revenue and Market Share by Type (2015-2020)
7.3.1 North America Antidote Sales Market Share by Type (2015-2020)
7.3.2 North America Antidote Revenue and Revenue Share by Type (2015-2020)
7.4 North America Antidote Sales Market Share by Application (2015-2020)
8 South America Antidote Market Size Categorized by Countries
8.1 South America Antidote Sales, Revenue and Market Share by Countries
8.1.1 South America Antidote Sales by Countries (2015-2020)
8.1.2 South America Antidote Revenue by Countries (2015-2020)
8.1.3 Brazil Antidote Sales and Growth Rate (2015-2020)
8.2 South America Antidote Revenue (Value) by Manufacturers (2018-2020)
8.3 South America Antidote Sales, Revenue and Market Share by Type (2015-2020)
8.3.1 South America Antidote Sales Market Share by Type (2015-2020)
8.3.2 South America Antidote Revenue and Revenue Share by Type (2015-2020)
8.4 South America Antidote Sales Market Share by Application (2015-2020)
9 Middle East and Africa Antidote Market Size Categorized by Countries
9.1 Middle East and Africa Antidote Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antidote Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Antidote Revenue by Countries (2015-2020)
9.1.3 GCC Countries Antidote Sales and Growth Rate (2015-2020)
9.1.4 Turkey Antidote Sales and Growth Rate (2015-2020)
9.1.5 Egypt Antidote Sales and Growth Rate (2015-2020)
9.1.6 South Africa Antidote Sales and Growth Rate (2015-2020)
9.2 Middle East and Africa Antidote Revenue (Value) by Manufacturers (2018-2020)
9.3 Middle East and Africa Antidote Sales, Revenue and Market Share by Type
9.3.1 Middle East and Africa Antidote Sales Market Share by Type (2015-2020)
9.3.2 Middle East and Africa Antidote Revenue and Revenue Share by Type (2015-2020)
9.4 Middle East and Africa Antidote Sales Market Share by Application (2015-2020)
10 Global Antidote Market Segment by Type
10.1 Global Antidote Revenue, Sales and Market Share by Type (2015-2020)
10.1.1 Global Antidote Sales and Market Share by Type (2015-2020)
10.1.2 Global Antidote Revenue and Market Share by Type (2015-2020)
10.2 Chemical Antidotes Sales Growth Rate and Price
10.2.1 Global Chemical Antidotes Sales Growth Rate (2015-2020)
10.2.2 Global Chemical Antidotes Price (2015-2020)
10.3 Physical Antidotes Sales Growth Rate and Price
10.3.1 Global Physical Antidotes Sales Growth Rate (2015-2020)
10.3.2 Global Physical Antidotes Price (2015-2020)
10.4 Pharmacological Antidotes Sales Growth Rate and Price
10.4.1 Global Pharmacological Antidotes Sales Growth Rate (2015-2020)
10.4.2 Global Pharmacological Antidotes Price (2015-2020)
11.1 Global AntidoteSales Market Share by Application (2015-2020)
11.2 Pesticide Poisoning Sales Growth Rate (2015-2020)
11.3 Heavy Metal Poisoning Sales Growth Rate (2015-2020)
11.4 Animal Bites Poisoning Sales Growth Rate (2015-2020)
11.5 Cyanide Poisoning Sales Growth Rate (2015-2020)
11.6 Others Sales Growth Rate (2015-2020)
12.1 Global Antidote Revenue, Sales and Growth Rate (2020-2027)
12.2 Antidote Market Forecast by Regions (2020-2027)
12.2.1 Europe Antidote Market Forecast (2020-2027)
12.2.2 APAC Antidote Market Forecast (2020-2027)
12.2.3 North America Antidote Market Forecast (2020-2027)
12.2.4 South America Antidote Market Forecast (2020-2027)
12.2.5 Middle East & Africa Antidote Market Forecast (2020-2027)
12.3 Antidote Market Forecast by Type (2020-2027)
12.3.1 Global Antidote Sales Forecast by Type (2020-2027)
12.3.2 Global Antidote Market Share Forecast by Type (2020-2027)
12.4 Antidote Market Forecast by Application (2020-2027)
12.4.1 Global Antidote Sales Forecast by Application (2020-2027)
12.4.2 Global Antidote Market Share Forecast by Application (2020-2027)
13 Analysis of Antidote Industry Key Manufacturers
13.1 Roche
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Roche Antidote Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.1.4 Main Business Overview
13.1.5 Roche News
13.2 Pfizer
13.2.1 Company Details
13.2.2 Product Information
13.2.3 Pfizer Antidote Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.2.4 Main Business Overview
13.2.5 Pfizer News
13.3 Bayer
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Bayer Antidote Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.3.4 Main Business Overview
13.3.5 Bayer News
13.4 Johnson & Johnson
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Johnson & Johnson Antidote Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.4.4 Main Business Overview
13.4.5 Johnson & Johnson News
13.5 Novartis
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Novartis Antidote Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.5.4 Main Business Overview
13.5.5 Novartis News
13.6 Eli Lilly
13.6.1 Company Details
13.6.2 Product Information
13.6.3 Eli Lilly Antidote Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.6.4 Main Business Overview
13.6.5 Eli Lilly News
13.7 Teva
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Teva Antidote Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.7.4 Main Business Overview
13.7.5 Teva News
13.8 Boehringer Ingelheim
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Boehringer Ingelheim Antidote Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.8.4 Main Business Overview
13.8.5 Boehringer Ingelheim News
13.9 Mylan
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Mylan Antidote Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.9.4 Main Business Overview
13.9.5 Mylan News
13.10 Fresenius Kabi
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Fresenius Kabi Antidote Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.10.4 Main Business Overview
13.10.5 Fresenius Kabi News
13.11 Baxter
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Baxter Antidote Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.11.4 Main Business Overview
13.11.5 Baxter News
13.12 Furen Pharmaceutical
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Furen Pharmaceutical Antidote Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
13.12.4 Main Business Overview
13.12.5 Furen Pharmaceutical News
15 Appendix